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Introduction
Both gap junctions and adhesion molecules play a crit-
ical role in cell contact inhibition, differentiation, pro-
liferation, and homeostasis of various tissues. Recent
evidence suggests that gap junctions are not simply
pore-forming proteins, but interact with cell adhesion-
associated proteins and participate in signalling events
[1-3].
Connexin 43 is one of the most common connexins
and the major connexin homolog expressed in lung tis-
sue [4-6]. Connexin 43 and E-cadherin play important
roles in carcinogenesis and tumour metastasis [7-9].
They are concurrently expressed in many tumours
[10,11]. Hernandez-Blazquez et al. indicated that E-
cadherin can regulate connexin 43 expression and
function [12]. However, it is still unclear that whether
connexin 43 and E-cadherin are concurrently
expressed in lung cancers and affect each other or not.
In this study, we examined the expression of connexin
43 and E-cadherin in primary lung cancers to clarify
the correlation between connexin 43 and E-cadherin,
and explore the clinical and pathological implications
of expression of these proteins. We also transfected
LH7 cells with connexin 43 gene and investigated the
possible effect of connexin 43 on E-cadherin.
Materials and Methods
Patients. A total of 107 samples and 15 corresponding normal lung
tissue samples were selected randomly from patients with squa-
mous cell carcinomas (SCC) or adenocarcinomas who underwent
surgery in the First Affiliated Hospital of China Medical Universi-
ty between 2001 and 2003. The study was conducted according to
institutional review board regulations at China Medical University.
There were 69 males and 38 females in our study, with ages rang-
ing from 33 - 76 years, (mean = 57 years). The tumours were diag-
nosed as SCC (n = 45) or adenocarcinomas (n = 62) [13]. These
tumours showed different degrees of differentiation and were clas-
sified as well- (n = 38), moderately- (n = 30), or poorly- (n = 39)
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differentiated [13]. Fifty-seven cases indicated lymphatic metasta-
sis. All the tumours were classified as stages I, II, and III-IV (n =
50, 30, and 27, respectively) [14,15]. All the resected specimens
were fixed with 10% neutral-buffered formalin and embedded in
paraffin blocks.
Immunohistochemistry. Tissue blocks were cut into 4-μm sec-
tions, deparaffinized, rehydrated, and immunostained with mono-
clonal anti-connexin 43 antibody (1:50; Santa Cruz Biotechnology,
USA) and monoclonal anti-E-cadherin antibody (1:100; Santa
Cruz Biotechnology, USA). Detection was performed using the
streptavidin-peroxidase method. Negative control slides were
stained in the absence of primary antibodies.
Based on the scale of Nemeth et al. [16], the immunostaining
grade of connexin 43 and E-cadherin was as follows: specimens in
which none, ≤ 25%, > 25% - < 75%, and ≥ 75% of tumour cells
showed positive staining were defined as (-), (+), (++), and (+++),
respectively. Samples scoring (-) - (+) were considered negative,
and those that scored (++) - (+++) were considered positive.
Cell culture and transfection. The LH7 cell line is derived from
the PG cell line, established from a human pulmonary giant cell
carcinoma. LH7 cells were a gift from Dr. Jie Zheng, College of
Medicine, Beijing University, China. LH7 cells are highly metasta-
tic and express low levels of connexin 43 [17, 18]. The LH7 cells
were grown in RPMI 1640 medium (GiBCO, USA) with 10% fetal
calf serum (GiBCO, USA), at 37°C in a humidified atmosphere
(5% CO2 95% air).
The connexin 43 expression vectors pcDNA3.1(+)-Cx43 were
obtained from Professor YW Zhang (Tokyo Medical and Dental
University, Japan) as a gift [2]. LH7 cells were transfected with
pcDNA3.1(+)-Cx43 or pcDNA3.1(+) as control using FuGENE 6
transfection reagent according to the manufacturer's instructions
(Roche, USA). After 36 h, the culture medium was changed and
G418 (Roche, USA) was added at a concentration of 350 μg/ml.
Culture medium was changed every three days. After four weeks
of selection, six neomycin resistant clones were selected and kept
in culture with the same concentration of G418 during every fol-
lowing experiment.
Western blot. LH7 cells transfected with pcDNA3.1(+)-Cx43
(called LH7-Gja1 cells) or pcDNA3.1(+) [called LH7(-) cells] were
lysed and separated by 10% SDS-PAGE, and were transferred to a
polyvinylidene fluoride membrane. The transferred samples were
further incubated with anti-connexin 43 antibody (1:300) and anti-
E-cadherin antibody (1:300) overnight. The proteins were visual-
ized with an automatic electrophoresis analytic system (ChemiI-
mager 5500, AlPha InnCh, USA). β-actin was used as internal con-
trol.
Immunofluorescence staining. Cells were fixed, permeablised
and incubated with anti-connexin 43 (1:300) and anti-E-cadherin
antibodies (1:300) overnight, and labelled with a FITC-conjugated
secondary antibody for 1 h, followed by staining with 0.1% DAPI
for 3 min. Cells examined using an immunofluorescence micro-
scope (BX60, OLYMPUS, Japan).
Cell cycle and proliferation. The cells were grown in a 96-well plate
at a density of 1.5 × 106 cells/ml for 48 h, and stained with 1 mg/ml
propidium iodide (Sigma, USA). The percentages of LH7-Gja1, LH7,
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Table 1. Expression of connexin 43 and E-cadherin and their relation to clinicopathologic characteristics.
or LH7(-) cells in G1 phase, G2 phase and S phase were determined
by flow cytometry (FACSCalibur, BD Biosciences, USA).
The CellTiter 96 AQueous cell proliferation assay (Promega,
USA) was performed to study alterations in cell proliferation,
according to the manufacturer's instructions. The absorbance at
490 nm, which is directly proportional to the number of living cells
in culture, was detected in LH7, LH7(-) and LH7-Gja1 cells each
day for 5 d after transfection.
Statistical analyses. The χ2 test was used to clarify the relationships
among connexin 43, E-cadherin and clinicopathologic characteris-
tics. The Mann and Whitney U test was used to analyze the results
of the western blot, cell growth rate, and cell cycle experiments. P
values less than 0.05 were considered statistically significant.
Results
Reduced expression of both connexin 43 
and E-cadherin is associated with poor 
differentiation, advanced TNM stages and
lymph node metastasis in lung cancers
Connexin 43 and E-cadherin were typically
expressed at the cell membrane in all 15 normal lung
tissues (Fig. 1a). However, in lung cancer tissues,
expression of connexin 43 was positive in only
50.5% (54/107) of samples. E-cadherin expression
was positive in only 67.3% (72/107) of lung cancer
samples. Expression of connexin 43 and E-cadherin
in the samples was primarily cytoplasmic, and mem-
brane expression was dramatically reduced (Figs. 1b
and 1c). Several samples showed simultaneous
nuclear and cytoplasmic expression (Fig. 1d). Corre-
lations between the clinicopathologic characteristics
of the samples and expression patterns of connexin
43 and E-cadherin are summarized in Table 1. Sig-
nificant reduction of connexin 43 and E-cadherin
expression was associated with patient samples that
are poorly-differentiated, had advanced TNM stages
and lymph node metastases. Reduced connexin 43
and E-cadherin levels were independent of tumour
histological types. Interestingly, expression of con-
nexin 43 and E-cadherin were significantly correlat-
ed with each other (P < 0.001, Contingency coeffi-
cient = 0.504; Table 1).
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Fig. 1. Expression of connexin 43 and E-cadherin in lung cancers and normal lung tissues. (a) upper left: membrane expression of E-cad-
herin in normal epithelial cells of tunica mucosa bronchiorum. Upper right and below: membrane expression of connexin 43 in normal
bronchial submucosal glands and alveolar epithelial cells. (b) E-cadherin expressed in cytoplasm of well-differentiated adenocarcinoma
cells. (c) Connexin 43 expressed in cytoplasm of poorly-differentiated squamous cell carcinoma cells. (d) Connexin 43 expressed in cyto-
plasm and nucleus of moderately-differentiated adenocarcinoma cells.
E-cadherin expression is recruited by connexin
43 transfection
After 4 weeks of G418 selection, stable LH7-Gja1 cell
clones were obtained. These clones were named
LH7Gja1#1, LH7Gja1#2, LH7Gja1#4, and LH7Gja1#6.
As shown in Fig. 2, the immunofluorescence detection
of connexin 43 and E-cadherin expression in the LH7-
Gja#1 clone is obviously stronger than in LH7 or LH7(-)
cells. However, localization of both proteins was cyto-
plasmic rather than at the cell surface. The western blot
results show that E-cadherin expression is significant-
ly recruited in LH7-Gja1 cells than in LH7 or LH7(-)
cells (P < 0.001, Fig. 3). 
Overexpression of connexin 43 inhibits cell
cycle transition and proliferation of LH7-Gja1
cells
The percentage of G1 phase cells in all the LH7-Gja1
cell clones was significantly higher than that of LH7 or
LH7(-) cells, while the percentages of LH7-Gja1 cells
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Fig. 2. Immunofluorescence of connexin 43 and E-cadherin in LH7, LH7(-) and LH7-Gja1 cells. The expression of connexin 43 and E-
cadherin in LH7 or LH7(-) cells is very low. After transfection, the expression of connexin 43 and E-cadherin is enhanced in LH7-Gja1
cells.
Fig. 3. Connexion 43 and E-cadherin expression in LH7, LH7(-)
and LH7-Gja1 cell clones. (a) After connexion 43 transfection,
expression was enhanced in LH7-Gja1 cell clones, LH7Gja1#1,
LH7Gja1#2, LH7Gja1#4, and LH7Gja1#6, compared with LH7 and
LH7(-) cells. Expression of E-cadherin (b) was greatly enhanced in
these cell clones, but not in LH7 or LH7(-) cells. β-actin served as
internal control. (c) The relative expression was quantified by the
ratios of connexion 43 or E-cadherin and β-actin. Expression of
connexin 43 and E-cadherin was significantly higher in LH7-Gja1
cells than in LH7 or LH7(-) cells (P < 0.001). The results are the
average of three independent experiments. 
in S and G2 phases were significantly lower than those
of LH7 or LH7(-) cells (P < 0.01, Fig. 4). Further exper-
iments showed that the growth rates of LH7-Gja1 cells
were also significantly lower than LH7 or LH7(-) cells
over one-week period in culture (P < 0.001, n = 3)
(Fig. 5). 
Discussion
The reduction of connexin 43 or E-cadherin has been
reported in several human cancers [7-9]. Our study
demonstrates that the concurrent reduction of connex-
in 43 and E-cadherin is significantly related to differ-
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Fig. 4. (a-c) Cell cycle distribution of LH7, LH7(-) and LH7-Gja1 clone (LH7Gja1#2) assayed by flow cytometry after PI staining. (d) His-
togram of LH7, LH7(-) and LH7-Gja1 cells. The bars represent the percentages of G1, S or G2 phase cells in LH7, LH7(-) or LH7-Gja1
cells. The results are the average of three independent experiments. 
Fig. 5. (a) Growth curves of LH7, LH7(-) and LH7-Gja1 clones. The absorbance at 490 nm represents viable cells. (b) Comparison of
viable cells among LH7, LH7(-) and LH7-Gja1 cells on the day of inoculation and at five days after inoculation. * vs. the day of inocula-
tion, # vs. LH7 cells and ‡ vs. LH7(-) cells. The results are the average of three independent experiments.
entiation and progression in 107 lung cancer samples.
Furthermore, overexpression of connexin 43 not only
restores the level of E-cadherin but also hampers pro-
liferation of human lung cancer cells.
Connexin 43 and E-cadherin expression and their
clinical/pathological correlations have not been well
documented in human lung cancers [8,18,19]. In a pre-
vious study of 24 cases, Jinn et al. reported that con-
nexin 43 was significantly decreased in poorly-differ-
entiated lung cancer. Immunostaining for E-cadherin
shows a heterogeneous decrease in expression [19].
Our study not only confirms this early report, but also
demonstrates that concurrent reduction of connexin 43
and E-cadherin is significantly related to poor differ-
entiation, advanced TNM staging and lymph node
metastasis. These results indicate that concurrent
reduction of connexin 43 and E-cadherin may reflect
cellular activity in cancer cells and progression of lung
cancer.
Earlier reports indicated that potential connections
exist between connexins and cadherins, and suggest
that cadherins might be a prerequisite for gap junction
formation [20,21]. Other reports suggest that E-cad-
herin regulates gap junction intercellular communica-
tion (GJIC) and involves posttranslational regulation
of connexin 43 [22,23]. Our results show that connex-
in 43 and E-cadherin are concurrently expressed in
77.6% of human lung cancer samples (including posi-
tive and negative expression of both proteins). Fur-
thermore, our study demonstrates that transfection
with connexin 43 gene in LH7 lung cancer cells
increases the expression of E-cadherin. The results
revealed that E-cadherin not only regulates expression
and function of connexin 43, but it is also induced by
connexin 43. The correlation and coordination
between E-cadherin and connexin 43 may have impor-
tant implications for regulating progression of lung
cancer.
Connexin 43 suppresses proliferation of cancer
cells by inhibiting cell cycle progression [24,25].
Zhang et al. [2,3,26] demonstrated that after transfec-
tion of connexin 43, the cell cycle transition from G1
to S phase of tumour cells was inhibited, whether GJIC
was present or not. These results further show that con-
nexin 43 increases the synthesis and decreases the
degradation of p27, and inhibits the expression of S-
phase kinase-associated protein 2 (Skp2). Consistent
with these findings, our study shows that although gap
junctions and cell adhesions were not clearly observed,
the proportion of cells in G1 is significantly increased
and the cells in S and G2 phases are significantly
decreased in LH7-Gja1 cells. These results indicate
that increased expression of cytoplasmic connexin 43
could still regulate cell cycle and inhibit proliferation
of lung cancer cells. Shima et al. [27] also observed
similar results in the cytoplasm of connexin 43-trans-
fected basaloid squamous cell carcinoma cells, sug-
gesting that connexin 43 may play a role as a tumour
suppressor.
In summary, we have shown that Concurrent
reduction of connexin 43 and E-cadherin may reflect
cellular activity in cancer cells and progression of
lung cancer. Connexin 43 may induce E-cadherin
expression and inhibit cell proliferation and progres-
sion of lung cancer.
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